BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17910625)

  • 21. Prognostic significance of a comprehensive histological evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients.
    Gianelli U; Fiori S; Cattaneo D; Bossi A; Cortinovis I; Bonometti A; Ercoli G; Bucelli C; Orofino N; Bulfamante G; Iurlo A
    Histopathology; 2017 Dec; 71(6):897-908. PubMed ID: 28710830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelofibrosis revisited: characterization and classification of myelofibrosis in the setting of myeloproliferative disease.
    Gilbert HS
    Prog Clin Biol Res; 1984; 154():3-17. PubMed ID: 6382299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia)--correlations between clinical and morphological features.
    Thiele J; Hoeppner B; Zankovich R; Fischer R
    Virchows Arch A Pathol Anat Histopathol; 1989; 415(3):191-202. PubMed ID: 2503923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities.
    Boiocchi L; Orazi A; Ghanima W; Arabadjief M; Bussel JB; Geyer JT
    Mod Pathol; 2012 Jan; 25(1):65-74. PubMed ID: 21841770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proplatelet production and stromal fibrosis in myeloproliferative neoplasms.
    Wilkins BS
    Leuk Res; 2010 Nov; 34(11):1417-9. PubMed ID: 20701970
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pathomechanism and clinical impact of myelofibrosis in neoplastic diseases of the bone marrow].
    Bedekovics J; Méhes G
    Orv Hetil; 2014 Mar; 155(10):367-75. PubMed ID: 24583557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
    Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
    Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic implications of collagen metabolism in myelofibrosis.
    Fruchtman SM
    Prog Clin Biol Res; 1984; 154():467-74. PubMed ID: 6382307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of stroma in human immunodeficiency virus/acquired immunodeficiency syndrome-affected bone marrows and correlation with CD4 counts.
    O'Malley DP; Sen J; Juliar BE; Orazi A
    Arch Pathol Lab Med; 2005 Sep; 129(9):1137-40. PubMed ID: 16119986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of bone marrow fibrosis and subsequent development of polycythemia in patients with myeloproliferative disorders.
    Talarico L; Wolf BC; Kumar A; Weintraub LR
    Am J Hematol; 1989 Apr; 30(4):248-53. PubMed ID: 2929585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.
    Åström M; Hahn-Strömberg V; Zetterberg E; Vedin I; Merup M; Palmblad J
    Am J Hematol; 2015 Mar; 90(3):E44-8. PubMed ID: 25421114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Histology of bone marrow in Vaquez's disease and the problem of myelosclerosis. 70 biopsies].
    Duhamel G; Najman A; André R
    Nouv Rev Fr Hematol; 1970; 10(2):209-22. PubMed ID: 4246273
    [No Abstract]   [Full Text] [Related]  

  • 33. Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies.
    Zahr AA; Salama ME; Carreau N; Tremblay D; Verstovsek S; Mesa R; Hoffman R; Mascarenhas J
    Haematologica; 2016 Jun; 101(6):660-71. PubMed ID: 27252511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models.
    Chagraoui H; Wendling F; Vainchenker W
    Best Pract Res Clin Haematol; 2006; 19(3):399-412. PubMed ID: 16781480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basic and 'special' stains for plastic sections in bone marrow histopathology, with special reference to May-Grünwald Giemsa and enzyme histochemistry.
    Bianco P; Ponzi A; Bonucci E
    Basic Appl Histochem; 1984; 28(3):265-79. PubMed ID: 6083774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic myelofibrosis: pathogenesis to treatment.
    Reilly JT
    Hematol Oncol; 2006 Jun; 24(2):56-63. PubMed ID: 16477581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic utility of bone marrow trephine biopsies.
    Sitalakshmi S; Srikrishna A; Devi S; Damodar P; Alexander B
    Indian J Pathol Microbiol; 2005 Apr; 48(2):173-6. PubMed ID: 16758657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of osteogenic growth peptide to the proliferation and differentiation of bone marrow stromal cells].
    Xiao Y; Wang JG; Bai ZL
    Zhongguo Gu Shang; 2008 Nov; 21(11):843-5. PubMed ID: 19143249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The development of myelofibrosis in prefibrotic cIMF. An investigation of the progression by sequential bone marrow biopsies in 38 patients].
    Buhr T; Länger F; Kreft A; Büsche G; Choritz H; Kreipe H
    Pathologe; 2002 Nov; 23(6):433-7. PubMed ID: 12436296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow and tumour stroma: an intimate relationship.
    Direkze NC; Alison MR
    Hematol Oncol; 2006 Dec; 24(4):189-95. PubMed ID: 16795113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.